|
ORC1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.521600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.619200E-01 |
| Normal-vs-Stage2 |
3.408000E-01 |
| Normal-vs-Stage3 |
6.064400E-01 |
| Normal-vs-Stage4 |
6.277200E-01 |
| Stage1-vs-Stage2 |
1.840720E-03 |
| Stage1-vs-Stage3 |
8.136600E-01 |
| Stage1-vs-Stage4 |
8.750200E-01 |
| Stage2-vs-Stage3 |
5.501400E-03 |
| Stage2-vs-Stage4 |
1.445880E-02 |
| Stage3-vs-Stage4 |
9.812400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.311000E-01 |
| Normal-vs-AfricanAmerican |
4.708200E-01 |
| Normal-vs-Asian |
9.461400E-01 |
| Caucasian-vs-AfricanAmerican |
7.600000E-01 |
| Caucasian-vs-Asian |
2.046600E-01 |
| AfricanAmerican-vs-Asian |
3.278800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.711000E-01 |
| Normal-vs-Female |
7.126800E-01 |
| Male-vs-Female |
5.587200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.778200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.175800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.099800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.508200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.632200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.078800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.431800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.211200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.782190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.366400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.807600E-01 |
| Classical-VS-Follicular |
4.21799999994477E-06 |
| Classical-VS-Other |
3.084200E-01 |
| Classical-VS-Normal |
4.600800E-01 |
| Tall-VS-Follicular |
2.363700E-04 |
| Tall-VS-Other |
1.512200E-01 |
| Tall-VS-Normal |
2.498400E-01 |
| Follicular-VS-Other |
6.141000E-01 |
| Follicular-VS-Normal |
2.574800E-01 |
| Other-VS-Normal |
6.571200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.069800E-01 |
| Normal-vs-N1 |
9.059400E-01 |
| N0-vs-N1 |
9.886800E-01 |
|
|
